M. Labelle

Tissue-Specific Regulation of Fat Cell Lipolysis by NPY in 6-OHDA-Treated Rats

A. Fournier, R. Savard, S. St.-Pierre, 1997, Peptides.

Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease

S. Chantal, C. Braun, Y. Boulanger, 2004, Brain Research.

Comparison of Metabolite Levels and Water Diffusion Between Cortical and Subcortical Strokes as Monitored by MRI and MRS

A. Khiat, M. Labelle, ANDRÉ Durocher, 2001, Investigative radiology.

Solution structure of neuropeptide tyrosine 13-36, a Y2 receptor agonist, as determined by NMR.

S. St.-Pierre, Y. Boulanger, M. Labelle, 1997, European journal of biochemistry.

Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease.

S. Chantal, C. Braun, Y. Boulanger, 2002, Archives of neurology.

Brain metabolic differences as a function of hemisphere, writing hand preference, and gender

C. Braun, Y. Boulanger, A. Khiat, 2002, Laterality.

Role of phospholipase A2 on the variations of the choline signal intensity observed by 1H magnetic resonance spectroscopy in brain diseases 1 1 Published on the World Wide Web on 10 August 2000.

Y. Boulanger, Abdesslem Khiat, Yvan Boulanger, 2000, Brain Research Reviews.

Three-dimensional structure of the Y1 receptor agonist [Leu31, Pro34]NPY as determined by NMR and molecular modeling.

Y. Boulanger, A. Khiat, M. Labelle, 2009, The journal of peptide research : official journal of the American Peptide Society.